NOVARTIS Alpha and Beta Analysis

<div class='circular--portrait' style='background:#347AFC;color: #ffffff;font-size:4em;padding-top: 25px;;'>NI</div>
NOVARTIND -- India Stock  

INR 553.85  14.95  2.63%

This module allows you to check different measures of market premium (i.e. an alpha and beta) for all equities including NOVARTIS INDIA LTD, as well as systematic risk associated with investing in NOVARTIS INDIA over a specified time horizon. Additionally, see Stocks Correlation.

Search Beta

Please note that although NOVARTIS INDIA alpha is a measure of relative return and represented here as a single number, it actually indicates the percentage above or below your selected benchmark (i.e., DOW index.) So in this particular case, NOVARTIS INDIA did 0.22  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of NOVARTIS INDIA LTD relative risk over its benchmark. NOVARTIS INDIA LTD has beta of 0.05  . As returns on market increase, returns on owning NOVARTIS INDIA are expected to decrease at a much smaller rate. During bear market, NOVARTIS INDIA is likely to outperform the market. Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility againt benchmark. The goal is to know if an investor is being compensated for the volatility risk taken.The return on investment might be better than a benchmark but still not compensate for the assumption of the volatility risk.

NOVARTIS INDIA Market Premiums

α-0.22   β-0.05
30 days against DJI


 Better Than Average     
 Worse Than Average Compare NOVARTIS INDIA to competition

NOVARTIS INDIA Fundamental Vs Peers

FundamentalsNOVARTIS INDIAPeer Average
Return On Equity3.86 (0.31) 
Return On Asset1.23 (0.14) 
Profit Margin5.02 (1.27) 
Operating Margin3.05 (5.51) 
Current Valuation8.73 B16.62 B
Shares Outstanding24.69 M571.82 M
Price to Earning59.72 28.72 

NOVARTIS INDIA Opportunities

NOVARTIS INDIA Return and Market Media

The median price of NOVARTIS INDIA for the period between Wed, Feb 26, 2020 and Tue, May 26, 2020 is 582.3 with a coefficient of variation of 11.88. The daily time series for the period is distributed with a sample standard deviation of 68.49, arithmetic mean of 576.25, and mean deviation of 54.85. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  

About NOVARTIS INDIA Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all equity instruments such as Ford or other stocks, funds, and ETFs. Alpha measures the amount that position in NOVARTIS INDIA LTD has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page